We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$988M
AUM Growth
-$950M
Cap. Flow
-$941M
Cap. Flow %
-95.22%
Top 10 Hldgs %
46.58%
Holding
205
New
16
Increased
16
Reduced
38
Closed
131

Top Buys

Rank Stock Value
1
QTRX icon
Quanterix
QTRX
+$23.5M
2
OM icon
Outset Medical
OM
+$11.4M
3
LIVN icon
LivaNova
LIVN
+$8.76M
4
CUTR
Cutera, Inc.
CUTR
+$5.89M
5
RCM
R1 RCM Inc. Common Stock
RCM
+$4.31M

Top Sells

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$26.8M
2
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$25.3M
3
BIIB icon
Biogen
BIIB
+$17.4M
4
ESTA icon
Establishment Labs
ESTA
+$15.9M
5
VRAY
ViewRay, Inc.
VRAY
+$14.1M

Sector Composition

Rank Sector Weight
1 Healthcare 31.61%
2 Industrials 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
176
Vertex Pharmaceuticals
VRTX
$133B
– –
-2,800
Closed -$809K
VSTM icon
177
Verastem
VSTM
$629M
– –
-83,689
Closed -$404K
XNTK icon
178
CALL
State Street SPDR NYSE Technology ETF
XNTK
$2.25B
– –
-99,200
Closed -$8.23M
CUTR
179
CALL
DELISTED
Cutera, Inc.
CUTR
– –
-242,500
Closed -$10.7M
NARI
180
PUT
DELISTED
Inari Medical, Inc. Common Stock
NARI
– –
-30,000
Closed -$1.91M
CERE
181
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
– –
-14,000
Closed -$442K
ALPN
182
DELISTED
Alpine Immune Sciences Inc
ALPN
– –
-30,924
Closed -$227K
NGM
183
CALL
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-60,300
Closed -$303K
NGM
184
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
– –
-83,154
Closed -$417K
NSTG
185
CALL
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-1,286,300
Closed -$10.3M
IMGN
186
DELISTED
Immunogen Inc
IMGN
– –
-50,000
Closed -$248K
NVTA
187
CALL
DELISTED
Invitae Corporation
NVTA
– –
-400,000
Closed -$744K
MRTX
188
CALL
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-122,200
Closed -$5.54M
MRTX
189
PUT
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
– –
-12,500
Closed -$566K
SYNH
190
CALL
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-150,000
Closed -$5.5M
ROIVW
191
DELISTED
Roivant Sciences Ltd. Warrant
ROIVW
– –
-199,648
Closed -$387K
KDNY
192
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
– –
-90,000
Closed -$2.36M
ISEE
193
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-229,600
Closed -$4.92M
ISEE
194
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-1,182,975
Closed -$25.3M
ISEE
195
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
– –
-19,700
Closed -$422K
RXDX
196
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-21,000
Closed -$2.31M
RXDX
197
PUT
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
– –
-12,500
Closed -$1.38M
CNCE
198
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-59,500
Closed -$347K
CNCE
199
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
– –
-206,525
Closed -$1.21M
TCDA
200
CALL
DELISTED
Tricida, Inc. Common Stock
TCDA
– –
-300,000
Closed -$45.9K
5 6 7
8
9

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCTC
Samsung C&T Corporation Seoul, South Korea $17.2M AUM 23.45% 1-Year Est. Return
M
MetLife New York $12.3M AUM 29% 1-Year Est. Return

Pura Vida Investments's Q1 2023 Portfolio in Review

As of Q1 2023, Pura Vida Investments held 205 positions worth $988M, down 49% from $1.94B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Pura Vida Investments withdrew a net $941M in Q1 2023, closing 131 positions and reducing 38 holdings. Its most notable exit was IVERIC bio, Inc. Common Stock, an estimated $25.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Industrials.

Against the trend, Pura Vida Investments opened a new position in Repligen worth $2.56M.

  • Pura Vida Investments's largest Q1 2023 buy was Repligen: 15,200 shares worth $2.56M.
  • Pura Vida Investments added most to Quanterix in Q1 2023, an estimated $23.5M increase.
  • Pura Vida Investments's biggest Q1 2023 reduction was Inspire Medical Systems, cutting an estimated $26.8M.
  • Pura Vida Investments fully exited IVERIC bio, Inc. Common Stock in Q1 2023, selling an estimated $25.3M.
  • Pura Vida Investments's ten largest holdings make up 47% of its $988M portfolio in Q1 2023.
  • Pura Vida Investments opened 16 new positions and closed 131 in Q1 2023.
  • Pura Vida Investments's portfolio value fell 49% quarter-over-quarter to $988M.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.